Promoting knowledge of statins in patients with low health literacy using an audio booklet

Patient Preference and Adherence

Volumn 5, Issue , 2011, Pages 397-403

  Travis Gossey, J ^a   Whitney, Simon N ^b   Crouch, Michael A ^c   Jibaja Weiss, Maria L ^b   Zhang, Hong ^d   Volk, Robert J ^d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Residency Program   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Hypercholesterolemia; Medical decision making; Patient adherence; Patient education

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; AUDIOVISUAL EQUIPMENT; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; HYPERLIPIDEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MYALGIA; PATIENT ASSESSMENT; PATIENT COUNSELING; PATIENT EDUCATION; RISK BENEFIT ANALYSIS; TREATMENT DURATION;

EID: 84866503937     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S19995     Document Type: Article

References (28)

1. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005; 366(9493): 1267-1278.
2. Ose L, Davidson MH, Stein EA, et al. Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol. 2000;23(1):39-46.
3. Avorn J, Monette J, Lacour A, et al. Persistence of use of lipidlowering medications: a cross-national study. JAMA. 1998;279(18): 1458-1462.
4. Howell N, Trotter R, Mottram D, Rowe P. Compliance with statins in primary care. Pharm J. 2004;272:223-226.
5. Insull W. The problem of compliance to cholesterol altering therapy. J Intern Med. 1997;241(4):317-325.
6. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462-467.
7. Mansur AP, Mattar AP, Tsubo CE, Simao DT, Yoshi FR, Daci K. Prescription and adherence to statins of patients with coronary artery disease and hypercholesterolemia. Arq Bras Cardiol. 2001;76(2):111-118.
8. Mantel-Teeuwisse AK, Goettsch WG, Klungel OH, de Boer A, Herings RM. Long term persistence with statin treatment in daily medical practice. Heart. 2004;90(9):1065-1066.
9. Tsuyuki RT, Bungard TJ. Poor adherence with hypolipidemic drugs: a lost opportunity. Pharmacotherapy. 2001;21(5):576-582.
10. Kruse W, Weber E. Dynamics of drug regimen compliance-its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol. 1990;38(6):561-565.
11. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
12. Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy. 2000;20(4):410-416.
13. LaRosa JH, LaRosa JC. Enhancing drug compliance in lipid-lowering treatment. Arch Fam Med. 2000;9(10):1169-1175.
14. Pearson T, Kopin L. Bridging the treatment gap: improving compliance with lipid-modifying agents and therapeutic lifestyle changes. Prev Cardiol. 2003;6(4):204-211.
15. Nielson-Bohlman L, Panzer AM, Kindig DA. Health Literacy: A Prescription to End Confusion. Washington, DC: Institute of Medicine, The National Academies Press; 2004.
16. DeWalt DA, Pignone MP. Reading is fundamental: the relationship between literacy and health. Arch Intern Med. 2005;165(17): 1943-1944.
17. Kirsch I, Jungeblut A, Jenkins L, Kolstad A. Adult Literacy in America: A First Look at the Findings of the National Adult Literacy Survey. Washington, DC: National Center for Education Statistics, US Department of Education; 1993.
18. Wolf MS, Gazmararian JA, Baker DW. Health literacy and functional health status among older adults. Arch Intern Med. 2005;165(17): 1946-1952.
19. Witte K, Meyer G, Martell D. Effective Health Risk Messages: A Step-by-Step Guide. Thousand Oaks, CA: Sage Publications Inc; 2001.
20. Baker DW, Williams MV, Parker RM, Gazmararian JA, Nurss J. Development of a brief test to measure functional health literacy. Patient Educ Couns. 1999;38(1):33-42.
21. Volk RJ, Spann SJ, Cass AR, Hawley ST. Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up. Ann Fam Med. 2003;1(1): 22-28.
22. Weymiller AJ, Montori VM, Jones LA, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med. 2007;167(10):1076-1082.
23. Sobel RM, Paasche-Orlow MK, Waite KR, Rittner SS, Wilson EA, Wolf MS. Asthma 1-2-3: a low literacy multimedia tool to educate African American adults about asthma. J Community Health. 2009;34(4):321-327.
24. Ostbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005;3(3):209-214.
25. Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003; 93(4):635-641.
26. Institute of Medicine. Speaking of Health: Assessing Health Communication Strategies for Diverse Populations. Washington, DC: The National Academies Press; 2002.
27. Hingorani AD, Psaty BM. Primary prevention of cardiovascular disease: Time to get more or less personal? JAMA. 2009;302(19): 2144-2145.
28. Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993-2000.